ENANTA PHARMACEUTICALS, INC Earnings Per Share (Basic)
ENANTA PHARMACEUTICALS, INC (ENTA) reported Earnings Per Share (Basic) of -$0.67 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-12
- ENANTA PHARMACEUTICALS, INC earnings per share, basic for the quarter ending 2026-06-30 was -$0.67.
- ENANTA PHARMACEUTICALS, INC earnings per share, basic for the quarter ending 2026-03-31 was -$0.45.
- ENANTA PHARMACEUTICALS, INC earnings per share, basic for the quarter ending 2025-12-31 was -$0.42.
- ENANTA PHARMACEUTICALS, INC earnings per share, basic for the quarter ending 2025-06-30 was -$0.85.
- ENANTA PHARMACEUTICALS, INC earnings per share, basic for fiscal 2025 was -$3.84.
- ENANTA PHARMACEUTICALS, INC earnings per share, basic for fiscal 2024 was -$5.48.
- ENANTA PHARMACEUTICALS, INC earnings per share, basic for fiscal 2023 was -$6.38.
- ENANTA PHARMACEUTICALS, INC earnings per share, basic for fiscal 2022 was -$5.91.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$0.67 10-Q · filed 2026-08-12 | -$1.54 10-Q · filed 2026-08-12 | ||
| 2026-03-31 | -$0.45 10-Q · filed 2026-05-13 | -$0.87 10-Q · filed 2026-05-13 | ||
| 2025-12-31 | -$0.42 10-Q · filed 2026-02-11 | |||
| 2025-09-30 | -$3.84 10-K · filed 2025-11-19 | |||
| 2025-06-30 | -$0.85 10-Q · filed 2026-08-12 | -$2.96 10-Q · filed 2026-08-12 | ||
| 2025-03-31 | -$1.06 10-Q · filed 2026-05-13 | -$2.11 10-Q · filed 2026-05-13 | ||
| 2024-12-31 | -$1.05 10-Q · filed 2026-02-11 | |||
| 2024-09-30 | -$5.48 10-K · filed 2025-11-19 | |||
| 2024-06-30 | -$1.07 10-Q · filed 2025-08-13 | -$4.12 10-Q · filed 2025-08-13 | ||
| 2024-03-31 | -$1.47 10-Q · filed 2025-05-14 | -$3.06 10-Q · filed 2025-05-14 | ||
| 2023-12-31 | -$1.58 10-Q · filed 2025-02-12 | |||
| 2023-09-30 | -$6.38 10-K · filed 2025-11-19 | |||
| 2023-06-30 | -$1.86 10-Q · filed 2024-08-07 | -$5.05 10-Q · filed 2024-08-07 | ||
| 2023-03-31 | -$1.79 10-Q · filed 2024-05-08 | -$3.19 10-Q · filed 2024-05-08 | ||
| 2022-12-31 | -$1.39 10-Q · filed 2024-02-08 | |||
| 2022-09-30 | -$5.91 10-K · filed 2024-11-27 | |||
| 2022-06-30 | -$1.53 10-Q · filed 2023-08-08 | -$4.64 10-Q · filed 2023-08-08 | ||
| 2022-03-31 | -$1.63 10-Q · filed 2023-05-09 | -$3.11 10-Q · filed 2023-05-09 | ||
| 2021-12-31 | -$1.48 10-Q · filed 2023-02-08 | |||
| 2021-09-30 | -$3.92 10-K · filed 2023-11-22 | |||
| 2021-06-30 | -$1.19 10-Q · filed 2022-08-08 | -$2.70 10-Q · filed 2022-08-08 | ||
| 2021-03-31 | -$1.09 10-Q · filed 2022-05-09 | -$1.51 10-Q · filed 2022-05-09 | ||
| 2020-12-31 | -$0.41 10-Q · filed 2022-02-10 | |||
| 2020-09-30 | -$1.46 10-K · filed 2020-11-25 | -$1.81 10-K · filed 2022-11-23 | ||
| 2020-06-30 | -$0.71 10-Q · filed 2021-08-09 | -$0.34 10-Q · filed 2021-08-09 | ||
| 2020-03-31 | -$0.30 10-Q · filed 2021-05-10 | $0.37 10-Q · filed 2021-05-10 | ||
| 2019-12-31 | $0.68 10-Q · filed 2021-02-09 | |||
| 2019-09-30 | $0.47 10-K · filed 2020-11-25 | $2.37 10-K · filed 2021-11-24 | ||
| 2019-06-30 | $0.36 10-K · filed 2020-11-25 | $1.90 10-Q · filed 2020-08-10 | ||
| 2019-03-31 | $0.21 10-K · filed 2020-11-25 | $1.55 10-Q · filed 2020-05-11 | ||
| 2018-12-31 | $1.34 10-K · filed 2020-11-25 | |||
| 2018-09-30 | $1.41 10-K · filed 2019-11-27 | $3.74 10-K · filed 2020-11-25 | ||
| 2018-06-30 | $1.05 10-K · filed 2019-11-27 | $2.32 10-Q · filed 2019-08-09 | ||
| 2018-03-31 | $0.65 10-K · filed 2019-11-27 | $1.27 10-Q · filed 2019-05-10 | ||
| 2017-12-31 | $0.61 10-K · filed 2019-11-27 | |||
| 2017-09-30 | $1.91 10-K · filed 2018-11-29 | $0.93 10-K · filed 2019-11-27 | ||
| 2017-06-30 | -$0.44 10-K · filed 2018-11-29 | -$0.99 10-Q · filed 2018-08-09 | ||
| 2017-03-31 | -$0.28 10-K · filed 2018-11-29 | -$0.54 10-Q · filed 2018-05-10 | ||
| 2016-12-31 | -$0.26 10-K · filed 2018-11-29 | |||
| 2016-09-30 | -$0.09 10-K · filed 2017-12-11 | $1.14 10-K · filed 2018-11-29 | ||
| 2016-06-30 | -$0.06 10-K · filed 2017-12-11 | $1.24 10-Q · filed 2017-08-09 | ||
| 2016-03-31 | -$0.09 10-K · filed 2017-12-11 | $1.30 10-Q · filed 2017-05-10 | ||
| 2015-12-31 | $1.39 10-K · filed 2017-12-11 | |||
| 2015-09-30 | $0.30 10-K · filed 2016-12-09 | $4.23 10-K · filed 2017-12-11 | ||
| 2015-06-30 | $0.13 10-K · filed 2016-12-09 | $3.92 10-Q · filed 2016-08-09 | ||
| 2015-03-31 | $1.54 10-K · filed 2016-12-09 | $3.80 10-Q · filed 2016-05-10 | ||
| 2014-12-31 | $2.26 10-K · filed 2016-12-09 | |||
| 2014-09-30 | -$0.27 10-K · filed 2015-12-11 | -$2.49 derived: net income ÷ weighted average shares · filed 2016-12-09 | -$6.68 derived: net income ÷ weighted average shares · filed 2016-12-09 | $1.88 10-K · filed 2016-12-09 |
| 2014-06-30 | $2.70 10-K · filed 2015-12-11 | $2.43 derived: net income ÷ weighted average shares · filed 2015-08-10 | $2.16 10-Q · filed 2015-08-10 | $1.92 derived: net income ÷ weighted average shares · filed 2015-12-11 |
| 2014-03-31 | -$0.28 10-K · filed 2015-12-11 | -$0.58 10-Q · filed 2015-05-08 | -$0.83 derived: net income ÷ weighted average shares · filed 2015-12-11 | -$1.06 derived: net income ÷ weighted average shares · filed 2015-12-11 |
| 2013-12-31 | -$0.30 10-K · filed 2015-12-11 | -$0.55 derived: net income ÷ weighted average shares · filed 2015-12-11 | -$0.78 derived: net income ÷ weighted average shares · filed 2015-12-11 | -$1.35 derived: net income ÷ weighted average shares · filed 2015-12-11 |
| 2013-09-30 | -$0.25 10-K · filed 2014-12-11 | -$0.48 derived: net income ÷ weighted average shares · filed 2015-12-11 | -$1.07 derived: net income ÷ weighted average shares · filed 2015-12-11 | -$0.67 10-K · filed 2015-12-11 |
| 2013-06-30 | -$0.23 10-K · filed 2014-12-11 | -$0.91 derived: net income ÷ weighted average shares · filed 2014-08-12 | -$0.30 10-Q · filed 2014-08-12 | -$1.38 derived: net income ÷ weighted average shares · filed 2014-12-11 |
| 2013-03-31 | -$2.28 10-K · filed 2014-12-11 | $1.21 10-Q · filed 2014-05-12 | -$2.39 derived: net income ÷ weighted average shares · filed 2014-12-11 | -$6.00 derived: net income ÷ weighted average shares · filed 2014-12-11 |
| 2012-12-31 | $1.61 10-K · filed 2014-12-11 | $1.25 derived: net income ÷ weighted average shares · filed 2014-12-11 | -$3.00 derived: net income ÷ weighted average shares · filed 2014-12-11 | -$0.69 derived: net income ÷ weighted average shares · filed 2014-12-11 |
| 2012-09-30 | -$4.78 10-K · filed 2013-12-18 | -$4.69 derived: net income ÷ weighted average shares · filed 2014-12-11 | -$2.38 derived: net income ÷ weighted average shares · filed 2014-12-11 | $1.26 10-K · filed 2014-12-11 |
| 2012-06-30 | -$4.31 10-K · filed 2013-12-18 | -$1.99 derived: net income ÷ weighted average shares · filed 2013-08-12 | $1.68 10-Q · filed 2013-08-12 | |
| 2012-03-31 | $2.41 10-K · filed 2013-12-18 | $2.06 10-Q · filed 2013-05-15 | ||
| 2011-12-31 | -$4.44 10-K · filed 2013-12-18 | |||
| 2011-09-30 | $1.40 10-K · filed 2013-12-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Emergent BioSolutions Inc. (EBS) | United States | $0.347B | -2.43 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |